Protocol for Prehabilitation Service Implementation in Catalonia

February 11, 2020 updated by: Josep Roca, Hospital Clinic of Barcelona
Trimodal prehabilitation consists of a short-term (~ four to six weeks) preventive intervention to: i) enhance aerobic capacity and daily physical activity; ii) nutritional optimization; and, iii) psychological support before a major surgical procedure. The final aim of prehabilitation is to decrease surgical complications and speed-up postoperative functional recovery.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This is a preventive intervention addressed to high risk candidates for major surgical procedures carried out for a period of approximately four weeks before surgery aiming at reducing complications and enhancing post-surgical recovery. It combines: i) high-intensity endurance exercise training and promotion of daily physical activity; ii) nutritional balance; and, iii) psychological support.

The intervention is currently deployed as mainstream service at Hospital Clinic in several types of major surgeries. During fall 2017, three multidisciplinary workshops using a design-thinking approach were carried out to refine the service workflow and to explore the potential for service scalability. The outcomes of the co-design process provided a robust background for the design of a future personalized perioperative care service at regional level covering three phases: prehabilitation, in-patient care, and, post-discharge care.

The current study protocol aims to assess cost-effectiveness of prehabilitation as mainstream service in the ongoing deployment at Hospital Clinic, as well as to generate a roadmap for regional scalability of the service. It is planned as a quasi-experimental case-control study including 500 patients undertaking prehabilitation, as intervention group, and 250 patients following standard conventional care before surgery. The patients will be included from the following type of surgeries (2:1 intervention to control ratio): major digestive surgery (n, 525), lung volume reduction (n, 30), radical cystectomy (n, 30), major cardiovascular surgery (n, 165). Study groups will be made comparable using propensity score matching with the following matching variables: type of surgery, age, sex and adjusted morbidity groups (GMA) scoring.

Study Type

Interventional

Enrollment (Actual)

750

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Catalonia
      • Barcelona, Catalonia, Spain, 08036
        • Hospital Clinic. Prehabilitation Unit D +34932275747 chernan@clinic.ub.es

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adult patients (>18 years old) candidates to colorectal surgery, esophagectomy, gastrectomy, gastric bypass, major liver resection, pancreas resection, lung volume resection, radical cystectomy, cardiac valve surgery or cardiac revascularization.
  • Patients at high-risk for surgical complications defined by age > 70 years old and/or American Society of Anesthesiologists 3-4.

Exclusion Criteria:

  • Non-elective surgery
  • Metastatic disease known preoperatively
  • Unstable cardiac or respiratory disease
  • Locomotor limitations precluding exercise performance
  • Cognitive deterioration impeding adherence to the program

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Prehabilitation + standard care
Trimodal Prehabilitation consisting on motivation, personalisation and supervision of physical activity before major surgery
Prehabilitation before major surgery consisting of: i) motivational interview to assess patient's adherence profile and to co-design the characteristics of the physical activity program with the patient; ii) personalised program to promote daily physical activity; and iii) supervised high-intensity endurance exercise training program.
No Intervention: Standard care
Standard care before major surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
cost-effectiveness
Time Frame: 4 weeks
Health care costs
4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complications
Time Frame: 4 weeks
number of complications per patient
4 weeks
Length of stay
Time Frame: 4 weeks
hospital and intensive care unit length of stay,
4 weeks
Number of hospital readmissions
Time Frame: 4 weeks
30-day hospital readmissions rate
4 weeks
Number of Emergency room visits
Time Frame: 4 weeks
30-day emergency room visits rate
4 weeks
Meters achieved in the six-minute walk test
Time Frame: 4 weeks
Aerobic capacity
4 weeks
Yale Physical Activity Survey (YPAS)
Time Frame: 4 weeks
Physical activity assessed by the YPAS (Range 0-100) Higher values represent better
4 weeks
Health status assessed by 36-Item Short Form Survey (SF-36)
Time Frame: 4 weeks
Health status related quality of life (Range 0-100) Higher values represent better
4 weeks
Psychological status assessed by the The Hospital Anxiety And Depression Scale (HAD)
Time Frame: 4 weeks
Psychological status (Range 0-21) Higher values represent worst
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Josep Roca, MD, Hospital Clínic

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2018

Primary Completion (Actual)

August 1, 2019

Study Completion (Actual)

October 1, 2019

Study Registration Dates

First Submitted

December 3, 2018

First Submitted That Met QC Criteria

December 5, 2018

First Posted (Actual)

December 6, 2018

Study Record Updates

Last Update Posted (Actual)

February 13, 2020

Last Update Submitted That Met QC Criteria

February 11, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • NEXTCARE-PREHAB

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Disease

Clinical Trials on Trimodal Prehabilitation

3
Subscribe